REGN1500 + placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypertriglyceridemia
Conditions
Hypertriglyceridemia
Trial Timeline
Dec 1, 2012 → Jan 1, 2016
NCT ID
NCT01749878About REGN1500 + placebo
REGN1500 + placebo is a phase 1 stage product being developed by Regeneron Pharmaceuticals for Hypertriglyceridemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01749878. Target conditions include Hypertriglyceridemia.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02107872 | Phase 1 | Completed |
| NCT01749878 | Phase 1 | Completed |
Competing Products
20 competing products in Hypertriglyceridemia